Skip to main content
Zoetis to acquire Abaxis for $1.9B
5/17/2018

Zoetis intends to spend $1.9 billion to acquire Abaxis, which makes blood and urine tests for vector-borne infections including heartworm and Lyme disease.

Full Story: